Federation des caisses Desjardins du Quebec’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-84
Closed -$8 2969
2025
Q4
$8 Hold
84
﹤0.01% 2865
2025
Q3
$51 Hold
84
﹤0.01% 2832
2025
Q2
$26 Hold
84
﹤0.01% 2694
2025
Q1
$41 Hold
84
﹤0.01% 2627
2024
Q4
$72 Hold
84
﹤0.01% 2498
2024
Q3
$714 Hold
84
﹤0.01% 2355
2024
Q2
$392 Hold
84
﹤0.01% 2280
2024
Q1
$571 Hold
84
﹤0.01% 2232
2023
Q4
$281 Hold
84
﹤0.01% 2243
2023
Q3
$209 Hold
84
﹤0.01% 2267
2023
Q2
$108 Hold
84
﹤0.01% 2271
2023
Q1
$68 Hold
84
﹤0.01% 2301
2022
Q4
$64 Hold
84
﹤0.01% 2436
2022
Q3
$78 Hold
84
﹤0.01% 2475
2022
Q2
$80 Hold
84
﹤0.01% 2508
2022
Q1
$177 Hold
84
﹤0.01% 2515
2021
Q4
$752 Hold
84
﹤0.01% 2442
2021
Q3
$1.39K Hold
84
﹤0.01% 2435
2021
Q2
$1.75K Hold
84
﹤0.01% 2396
2021
Q1
$1.57K Hold
84
﹤0.01% 2340
2020
Q4
$1.85K Hold
84
﹤0.01% 2203
2020
Q3
$1.74K Hold
84
﹤0.01% 2015
2020
Q2
$3.04K Hold
84
﹤0.01% 1894
2020
Q1
$2.75K Buy
+84
New +$3.4K ﹤0.01% 1947

Federation des caisses Desjardins du Quebec's APLT Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 84 shares — an estimated $8 sold.

Federation des caisses Desjardins du Quebec first reported a position in APLT in Q1 2020 and held it in 24 quarters. The position peaked at $3.04K in Q2 2020. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • Federation des caisses Desjardins du Quebec reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 84 Applied Therapeutics shares in Q1 2026, an estimated $8.
  • Federation des caisses Desjardins du Quebec first reported a position in Applied Therapeutics in Q1 2020 and held it in 24 quarters.
  • Federation des caisses Desjardins du Quebec's Applied Therapeutics position peaked at $3.04K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.